BackGrape King Bio Overview

Grape King Bio Receivables

Grape King Bio's receivables is $360M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$356.08M
↓ 3.45% YoYΔ $-12.73M vs prior year quarter

Peer trimmed avg / median

Loading

Grape King Bio Receivables History

Loading

Grape King Bio vs. peers: Receivables Comparison

Loading

Grape King Bio Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Grape King Bio (1707.TW) FAQ

Grape King Bio (1707.TW) currently reports a receivables of $360M as of June 2026. That compares with $370M in the prior-year period — down 3.5% year over year. Use the charts on this page to explore Grape King Bio's receivables history and peer comparisons.

Grape King Bio's receivables decreased from $370M to $360M — a 3.5% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Grape King Bio reported $360M in receivables as of June 2026. That compares with $370M in the prior-year period — down 3.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $360M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Grape King Bio, and consider following 1707.TW for alerts when major investors trade the stock.